MTIP AG

MTIP AG is a distinguished private equity firm based in Basel, Switzerland, specializing in growth-stage healthtech companies across Europe and selectively in North America. The firm focuses on identifying and scaling innovative businesses within the digital health, diagnostics, medical devices, and biotech services sectors. MTIP's investment strategy is centered on providing significant capital and strategic support to companies that have demonstrated strong revenue growth and are poised for further expansion. They target businesses with revenues typically ranging between CHF 10 million and CHF 50 million, indicating a focus on established, yet still rapidly growing, enterprises.

The firm's approach goes beyond capital injection, emphasizing active partnership with portfolio companies. MTIP leverages its deep industry expertise, extensive network, and operational support to help management teams accelerate growth, optimize operations, and pursue strategic initiatives such as market expansion or M&A. This hands-on methodology aims to unlock value and drive sustainable long-term success for their investments. Their commitment to the healthtech sector is underscored by their dedicated focus, allowing them to develop specialized insights into the evolving landscape of healthcare innovation.

MTIP manages substantial capital, notably with the MTIP Growth Gateway II fund, which successfully closed at CHF 250 million. This fund is designed to make significant minority or majority investments, with a typical investment size ranging from CHF 15 million to CHF 40 million per company. The fund aims to build a concentrated portfolio of 8 to 12 high-potential companies, ensuring a focused approach to value creation. Through its strategic investments, MTIP plays a crucial role in fostering the development of technologies and services that are transforming the global healthcare industry.